Opthea

Manufacturing · Australia · 11-50 Employees

View Company Info for Free

Overview

Headquarters

L 4 650 Chapel St, South Yarra, Victoria...

Revenue

<$5 Million

Stock Symbol

OPT

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Opthea

Opthea is a biopharmaceutical company focused on developing innovative therapies to treat vision-threatening eye diseases, particularly wet age-related macular degeneration (AMD) and diabetic macular edema (DME). The company is engaged in pioneering research and clinical trials to improve sight in patients suffering from these conditions. Additionally, Opthea is exploring treatments for lymphangioleiomyomatosis (LAM), a rare disorder with significant unmet medical needs. Their target audience includes patients with retinal diseases and healthcare professionals involved in ophthalmology.Explore more
Opthea's Social MediaSIC Code 28,283NAICS Code 32,325Ticker ASX: OPTShow more

Opthea Org Chart

PhoneEmail
SM
Australia flag for contact location.

Chief Operating Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Opthea

Compare insights from companies similar to Opthea, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Opthea

<$5M
11-50
Public
$383M
2015
SM
Stuart MudgeChief Operating Officer
$74.5M
11-50
Public
-
2001
JP
Jonathan PilcherCEO & Managing Director
11-50
Public
$140M
2001
DM
Deanne MillerChief Operating Officer
Illustration of an envelope

Opthea Tech Stack

A closer look at the technologies used by Opthea

Top Manufacturing Companies

Frequently Asked Questions Regarding Opthea

What is Opthea's stock symbol?
Opthea's stock symbol is OPT
What is Opthea's official website?
Opthea's official website is www.opthea.com
What is Opthea's Revenue?
Opthea's revenue is <$5 Million
What is Opthea's SIC code?
Opthea's SIC: 28,283
What is Opthea's NAICS code?
Opthea's NAICS: 32,325
How many employees does Opthea have?
Opthea has 11-50 employees
What industry does Opthea belong to?
Opthea is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Opthea competition?
Opthea top competitors include: Immutep, Neuren Pharmaceuticals
What companies has Opthea acquired?
Opthea has acquired the companies: Vegenics
What technology does Opthea use?
Some of the popular technologies that Opthea uses are: WordPress.org, Cloudflare Website Optimization, Neto, SecurePay
What does Opthea do?

Opthea is a biopharmaceutical company focused on developing innovative therapies to treat vision-threatening eye diseases, particularly wet age-related macular degeneration (AMD) and diabetic macular edema (DME). The company is engaged in pioneering research and clinical trials to improve sight in patients suffering from these conditions. Additiona... lly, Opthea is exploring treatments for lymphangioleiomyomatosis (LAM), a rare disorder with significant unmet medical needs. Their target audience includes patients with retinal diseases and healthcare professionals involved in ophthalmology.Read More

What are Opthea social media links?
Opthea Linkedin page Opthea Twitter page Opthea Facebook page
Who invested in Opthea?
Opthea has 4 investors including Carlyle Group, Carlyle Group, Abingworth and Undisclosed.
Is Opthea a public company?
Yes, Opthea is a public company and is traded under the symbol OPT
See more information about Opthea

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.